IRCT20170513033941N66招募中3 期
Comparison of the effects of pioglitazone and linagliptin on glycemic control, lipid profile, and hs-CRP in patients with type 2 diabetes mellitus under treatment with metformin
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 50 years（—）
- 性别
- All
入选标准
- •Patients diagnosed with type 2 diabetes
- •Individuals aged 30-50 years old
- •under treatment with metformin for at least 3 months
排除标准
- •Secondary diabetes due to cushing syndrome, acromegaly and other diseases
- •systemic inflammatory diseases such as rheumatoid arthritis, IBD, vasculitis, etc.
- •renal or liver or heart failure
- •under insulin therapy
- •unwillingness to cooperate
研究者
相似试验
招募中
3 期
Effect of Pioglitazone and ClobetasolIRCT20210926052596N1Tehran University of Medical Sciences40
已完成
2 期
Comparison the treatment effect of Pioglithazone with Metformin in patients withNon Alcoholic SteatoHepatitis (NASH)Fatty liver.fatty (change of) liver, not elsewhere classifiedIRCT201105026361N1Vice chancellor for research, Kashan University of Medical Sciences and Health Services80
进行中（未招募）
不适用
Comparison of the Effects of Pioglitazone vs. Placebo when given in addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus and Renal Failure – The PIOren Study - PIOren StudyThe study population will consist of insufficiently controlled patients with type 2 diabetes with renal failure requiring dialysisMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2007-006744-21-DETakeda Pharma GmbH
招募中
3 期
comparison the teraputic effect of pioglitazone and carnitine to metformin and carnitine in patients with non alcoholic fatty liver diseasenon alcoholic fatty liver disease (NAFLD).Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20190701044062N3Tabriz University of Medical Sciences80
已完成
3 期
comparison the therapeutic effect of pioglitazone and carnitine to pioglitazone and vitamin E in patients with non alcoholic fatty liver diseaseIRCT20190701044062N8Tabriz University of Medical Sciences80